Breast Cancer Cells-Breast Cancer Drug-Cancer Treatment-Chest Radiation

New breast cancer drug halts tumor growth better than standard therapy

A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a phase III clinical trial. read more..

source:http://www.sciencedaily.com

Chest Radiation for Girls Is Linked to Breast Cancer Later

Women who were exposed to chest radiation to treat cancer during childhood have a risk of developing breast cancer as adults that is comparable to that of women with a high genetic risk of the disease, according to a study being presented Monday. (Source: WSJ.com: Health) read more..

source:http://www.medworm.com

Genentech's Trastuzumab Emtansine (T-DM1) Reduces The Risk Of Cancer Worsening

Roche announced today that it's division, known as Genentech, has produced positive results in a phase three EMILIA study of a drug called trastuzumab emtansine (T-DM1). Genentech says that the drug met the endpoint target for the trial, showing marked improvement for women with HER2-positive metastatic breast cancer... read more..

source:http://www.medicalnewstoday.com

Breast Cancer Cell Survival-Psychometric Evaluation-Endoplasmic Reticulum-Breast Cancer Cells

ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways

Conclusions:ERLIN2 may confer a selective growth advantage for breast cancer cells by facilitating a cytoprotective response to various cellular stresses associated with oncogenesis. The information provided here sheds new light on the mechanism of breast cancer malignancy. (Source: BMC Cancer) read more..

source:http://www.medworm.com

Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery

Conclusions:The decision quality instrument met the criteria of feasibility, reliability, discriminant and content validity in this sample. Additional research to examine performance of the instrument in prospective studies and more diverse populations is needed. (Source: BMC Medical Informatics and Decision Making - Latest articles) read more..

source:http://www.medworm.com

Duloxetine Useful in Chemo Neuropathy, But Avoid ALCDuloxetine Useful in Chemo Neuropathy, But Avoid ALC

The antidepressant alleviated chemotherapy-induced neuropathy in what is described at a practice-changing trial, but patients with breast cancer should avoid acetyl-L-carnitine (ALC) supplements. Medscape Medical News (Source: Medscape Today Headlines) read more..

source:http://www.medworm.com

American Society Of Clinical Oncology-Cancer-Related Fatigue-Non-Hodgkin Lymphoma

Trastuzumab Emtansine, An Investigational Breast Cancer Drug, Halts Tumor Growth Better Than Standard Therapy

A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute... read more..

source:http://www.medicalnewstoday.com

Cancer Patients Fight Fatigue With Ginseng

High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had breast cancer. The findings were presented at the American Society of Clinical Oncology's annual meeting... read more..

source:http://www.medicalnewstoday.com

Type 2 diabetes ups risk of developing blood cancer by 20pc

Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis. read more..

source:http://www.bignewsnetwork.com

Duke University Medical Center-Breast Cancer Research-Breast Cancer Patients-Breast Cancer Cells

CD44 enhances invasion of basal-like breast cancer cells by up-regulating serine protease and collagen-degrading enzymatic expression and activity

Conclusion:HA-induced CD44 signaling increases a diverse spectrum of protease activity to facilitate the invasion associated with BL-BCa cells, providing new insights into the molecular basis of CD44-promoted invasion. (Source: Breast Cancer Research) read more..

source:http://www.medworm.com

Cardio fitness levels of breast cancer patients may affect survival

(Duke University Medical Center) Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center. (Source: EurekAlert! - Cancer) read more..

source:http://www.medworm.com

Innovative Computer Modeling Techniques Enable Creation Of New Anti-Cancer Drug

A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers... read more..

source:http://www.medicalnewstoday.com

Human Epidermal Growth Factor Receptor 2-Immunohistochemical-Breast Cancer Cells

BOND™ ORACLE™ Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System

The BOND™ ORACLE™ Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System is a laboratory test that measures how much HER2 protein is being made by breast cancer cells. The test uses a technique that will specifically recognize.. (Approved: 4/13/2012) (Source: Medical Device Approvals) read more..

source:http://www.medworm.com

Epidermal Growth Factor Receptor-Consumer Information-Immunohistochemical-Breast Cancer Cells

Consumer Information on: BOND? ORACLE? Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System - P090015

The BOND? ORACLE? Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System is a laboratory test that measures how much HER2 protein is being made by breast cancer cells. The test uses a technique that will specifically recognize.. (Source: Food and Drug Adminstration (FDA): CDRHNew) read more..

source:http://www.medworm.com

Amplified in breast cancer 1 oncogene enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways

Conclusion: AIB1 plays an important role in proliferation and chemoresistance of CCA through simultaneous activation of Akt and Nrf2 pathways, suggesting that AIB1 is a potential molecular target for CCA treatment. (HEPATOLOGY 2012) (Source: Hepatology) read more..

source:http://www.medworm.com

Hasbro Children's Hospital-Molecular Interactions-Breast Cancer Cells-Brown University

Protein 'jailbreak' helps breast cancer cells live

(Brown University) Researchers at Brown University and Hasbro Children's Hospital have traced the molecular interactions that allow the protein survivin to escape the nucleus of a breast cancer cell and prolong the cell's life. The study may help in the development of better therapies and prognostics. (Source: EurekAlert! - Cancer) read more..

source:http://www.medworm.com

Biologists Uncover Surprising Connection-Stages Of Breast Cancer Metastasis-Rensselaer Polytechnic Institute

Biologists uncover surprising connection between breast cancer cells and surrounding tissue

(Rensselaer Polytechnic Institute) Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis. (Source: EurekAlert! - Medicine and Health) read more..

source:http://www.medworm.com

Embryonic Development-Breast Cancer Cells-Cancer Center

Embryonic Development Protein Active In Cancer Growth

A team of scientists at the University of California, San Diego Moores Cancer Center has identified a novel protein expressed by breast cancer cells - but not normal adult tissues - that could provide a new target for future anti-cancer drugs and treatments. Led by Thomas J... read more..

source:http://www.medicalnewstoday.com